Michael Dougherty joined Marinus Pharmaceuticals Inc.'s board as a director.
Dougherty was most recently Celator Pharmaceuticals Inc.'s executive chairman.
Discover more about S&P Global’s offerings
Marinus appoints director
Insight Weekly: Ukraine war impact on mining; US bank growth slowdown; cloud computing headwinds
Insight Weekly: Cryptocurrency's growth; green bond market outlook; coal investors' windfall
Global M&A By the Numbers: Q1 2022
Insight Weekly: Challenges for European banks; Japan's IPO slowdown; carmakers' supply woes
Michael Dougherty joined Marinus Pharmaceuticals Inc.'s board as a director.
Dougherty was most recently Celator Pharmaceuticals Inc.'s executive chairman.